Crossmark

Docetaxel, cyclophosphamide, and epirubicin: application of PBPK modeling to gain new insights for drug-drug interactions

Published Online: 2024-03-30

Published Print: 2024-08

Authors

Li, Tongtong

Zhou, Sufeng

Wang, Lu

Zhao, Tangping

Wang, Jue

Shao, Feng
License Information

Text and Data Mining valid from 2024-03-30

Version of Record valid from 2024-03-30
More Information

Article History

Received: 25 December 2023

Accepted: 20 February 2024

First Online: 30 March 2024

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current